However, GM-CSF expression or activity at levels above or below the threshold at the maternal–fetal interface induces pregnancy complications such as preeclampsia (PE) and fetal growth restriction (FGR) related to insufficient placental development and function [63]. This evidence concerns the gene CSF2 and preeclampsia.